| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_SHPRH_0006000 | Exon-Exon | chr6:146209156-146264938 | chr6:145888020-145943802 | 256 nt | 0.3828 |
| hsa_SHPRH_0004900 | Exon-Exon | chr6:146209156-146271618 | chr6:145888020-145950482 | 250 nt | 0.3280 |
| hsa_SHPRH_0005000 | Exon-Exon | chr6:146209156-146273614 | chr6:145888020-145952478 | 250 nt | 0.2880 |
| hsa_SHPRH_0006100 | Exon-Exon | chr6:146209156-146275989 | chr6:145888020-145954853 | 81 nt | 0.3580 |
| hsa_chr6_0217300 | Intergenic-Intergenic | chr6:146209526-146209716 | chr6:145888390-145888580 | 191 nt | 0.4974 |
| hsa_chr6_0217400 | Intergenic-Intergenic | chr6:146209538-146210501 | chr6:145888402-145889365 | 964 nt | 0.4523 |
| hsa_chr6_0217500 | Intergenic-Intergenic | chr6:146213801-146214031 | chr6:145892665-145892895 | 231 nt | 0.3550 |
| hsa_SHPRH_0006600 | Exon-Exon | chr6:146214351-146215372 | chr6:145893215-145894236 | 87 nt | 0.3333 |
| hsa_SHPRH_0006400 | Exon-Exon | chr6:146214351-146240627 | chr6:145893215-145919491 | 866 nt | 0.4342 |
| hsa_SHPRH_0006500 | Exon-Exon | chr6:146214351-146243484 | chr6:145893215-145922348 | 1155 nt | 0.4268 |
A review of literature indicates that the circSHPRH is a tumor suppressor in brain cancer, specifically glioblastoma, where it is downregulated and its encoded SHPRH-146aa peptide inhibits glioma growth [Di Agostino et al. DOI:10.3389/fcell.2020.00389]. A review of human studies indicates that the circSHPRH is downregulated in colorectal cancer tissues and is associated with metastasis and survival, while its overexpression inhibits proliferation and cell cycle progression [Lee et al. DOI:10.1016/j.biopha.2018.12.052].